Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Hartmut Retzlaff resigns from office
Bad Vilbel, August 15, 2016 – Today STADA Arzneimittel AG and its long-serving chairman of the management board Hartmut Retzlaff agreed on terminating their service relationship due to personal circ...
FDA grants breakthrough therapy designation for depression drug
Following successful phase II trials, the US Food and Drug Administration (FDA) have granted a Breakthrough Therapy Designation for Janssen‘s esketamine, an antidepressant medication, for th...
CASI Pharmaceuticals Provides Update On Phase 2 Trial Of ENMD-2076 In Fibrolamellar Carcinoma
ROCKVILLE, MD, USA I August 16, 2016 I CASI Pharmaceuticals, Inc.
Merck cuts 148 jobs after giving up on ex-blockbuster hopeful Zontivity
Merck & Co.
EMA nails Artemis India plant over simvastatin API manufacturing issues
Another Indian API maker is in trouble over manufacturing issues.
Why is breast cancer common but heart cancer rare?
Malignant cancers strike certain organs, such as the colon or breast, more often than others.
AVEO Initiates the Evaluation of Tivozanib in Combination with Bristol-Myers Squibb’s Opdivo® (nivolumab) in Advanced Renal Cell Carcinoma
CAMBRIDGE, MA, USA I August 15, 2016 I AVEO Oncology (NASDAQ.
Agilent Technologies to Build New Facility in Colorado, Increasing Pharmaceutical Manufacturing Capacity
SANTA CLARA, Calif.
Vertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis
BOSTON, MA, USA - August 15, 2016 - Vertex Pharmaceuticals Incorporated (Nasdaq.
Pain reliever eliminates Alzheimer's symptoms – in mice
Mefenamic acid is a non-steroidal anti-inflammatory drug, commonly used to relieve period pain.
Endo Announces OPANA® ER Regulatory Update
DUBLIN, Ireland -- August 12, 2016 -- Endo International plc (NASDAQ.
AstraZeneca sees big share price rise, but it's not all the CEO's making
When AstraZeneca ($AZN) CEO Pascal Soriot warded off Pfizer’s hostile takeover, he promised to transform the company into something even better.
608
609
610
611
612
613
614
615
616
